Login

Biotech Acquisition Co

No Longer Reporting

The company has not filed an annual or quarterly report since its Q3 FY2022 10-Q, filed Nov 22, 2022. Its latest SEC filing is a SC 13G/A from Feb 14, 2024.

The sections below describe the company as of the FY2021 annual report.

What Did They Do?

Seeks to combine with businesses, focusing its search on healthcare companies.

How Were They Changing?

Since the FY2021 annual report
Latest quarter: Q3 FY2022, the three months to Sep 30, 2022
Net income
▼ −57%
vs $2.9M in Q3 FY2021
  • Feb 2, 2023 Company ends extension plan and begins liquidation After the investor could not deposit extension funds, the company said it would dissolve and redeem its public shares.
  • Jun 13, 2022 Company and Blade terminate merger agreement The proposed Blade business combination will not be completed; the company said it would continue seeking another target.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support